Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial
Status:
Completed
Trial end date:
2023-12-27
Target enrollment:
Participant gender:
Summary
This will be a placebo-controlled, multicenter-randomized prospective study of CPLE (Carica
papaya leaf extract) tabs in dengue patients (WHO-Group A, B). The study will enroll 300
eligible dengue cases into two arms: one arm receiving CPLE 1000mg t.i.d for 5 days and the
other group receiving a placebo.
The main question to ask is whether CPLE reduces severe disease progression and increases
platelet counts in dengue patients.
The participant will be asked to take orally available CPLE capsules at a dose of 1000 mg (2
capsules, 500mg each) or identical placebo three times a day for 5 days
Phase:
Phase 3
Details
Lead Sponsor:
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Collaborator:
Institute of Technology Transfer and Innovation (ITTI)